Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists

Giovanni Filocamo, Antonella Buoncompagni, Stefania Viola, Anna Loy, Clara Malattia, Angelo Ravelli, Alberto Martini

Research output: Contribution to journalArticlepeer-review


Four children with Takayasu's arteritis were treated with tumor necrosis factor antagonists because of disease relapse during conventional therapy or as a first-line agent. Two patients went into remission; in the other 2, the response was partial. Anti-tumor necrosis factor agents can have a role in the treatment of Takayasu's arteritis; further controlled studies are required.

Original languageEnglish
Pages (from-to)432-434
Number of pages3
JournalJournal of Pediatrics
Issue number3
Publication statusPublished - Sept 2008

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Treatment of Takayasu's Arteritis with Tumor Necrosis Factor Antagonists'. Together they form a unique fingerprint.

Cite this